Biancalani, Tommaso http://orcid.org/0000-0001-9104-9755
Scalia, Gabriele http://orcid.org/0000-0003-3305-9220
Buffoni, Lorenzo http://orcid.org/0000-0002-8191-3375
Avasthi, Raghav
Lu, Ziqing
Sanger, Aman
Tokcan, Neriman
Vanderburg, Charles R. http://orcid.org/0000-0001-8979-5054
Segerstolpe, Åsa
Zhang, Meng http://orcid.org/0000-0002-9753-0635
Avraham-Davidi, Inbal
Vickovic, Sanja http://orcid.org/0000-0003-0985-9885
Nitzan, Mor
Ma, Sai http://orcid.org/0000-0002-9785-7929
Subramanian, Ayshwarya
Lipinski, Michal http://orcid.org/0000-0001-8200-5056
Buenrostro, Jason
Brown, Nik Bear
Fanelli, Duccio http://orcid.org/0000-0001-8545-9424
Zhuang, Xiaowei http://orcid.org/0000-0002-6034-7853
Macosko, Evan Z. http://orcid.org/0000-0002-2794-5165
Regev, Aviv http://orcid.org/0000-0003-3293-3158
Article History
Received: 13 August 2020
Accepted: 11 August 2021
First Online: 28 October 2021
Competing interests
: A.R. is a cofounder and an equity holder of Celsius Therapeutics and an equity holder of Immunitas, and was a scientific advisory board member of ThermoFisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov. From 1 August 2020, A.R. has been an employee of Genentech. From 1 January 2021, G.S. has been an employee of Roche. From 1 February 2021, T.B. has been an employee of Genentech. X.Z. is a cofounder of and consultant for Vizgen.